Scientific Session
Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
Hector Chinoy, PhD, MBBS, MSc, FRCP
The University of Manchester
Manchester, United Kingdom
Disclosure(s): AstraZeneca: Advisor or Review Panel Member (Ongoing); Biogen: Consultant (Ongoing); Eli Lilly: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Consultant (Ongoing); Orphazyme: Consultant (Ongoing); Pfizer: Advisor or Review Panel Member (Ongoing); UCB: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)